Altered circulating endothelial progenitor cells in patients with keloid
G-Y Zhang1,2, L-C Wu3, T Liao4
1Department of Plastic and Reconstructive Surgery, Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
Clinical and Experimental Dermatology
|July 1, 2015
Summary
This study found increased circulating endothelial progenitor cells (EPCs) in keloid patients compared to healthy controls. Elevated vascular endothelial growth factor (VEGF) was also observed, though not correlated with EPC levels.
Area of Science:
- Dermatology and Regenerative Medicine
- Vascular Biology
- Cellular and Molecular Medicine
Background:
- Vascular endothelial growth factor (VEGF) is implicated in keloid formation.
- Endothelial progenitor cells (EPCs) regulate endothelial function and repair.
- Circulating EPC levels in keloid patients remain unexplored.
Purpose of the Study:
- To investigate the number of circulating EPCs in patients with keloid.
- To compare circulating EPC and VEGF levels between keloid patients and healthy controls.
Main Methods:
- Flow cytometry was used to quantify circulating EPCs (CD45- CD34+CD133+VEGFR2+ cells).
- Enzyme-linked immunosorbent assay (ELISA) measured plasma VEGF levels.
- Study included 39 keloid patients and 22 healthy controls.
Main Results:
- Circulating EPCs were detected in the peripheral blood of keloid patients.
- Patients with keloid exhibited significantly higher numbers of circulating EPCs compared to healthy controls.
- Plasma VEGF levels were also significantly elevated in keloid patients versus controls.
- No significant correlation was found between circulating EPC counts and serum VEGF levels.
Conclusions:
- This study presents the first evidence of increased circulating EPCs in keloid patients.
- Elevated EPCs may play a role in keloid pathogenesis.
- Further research into EPC function in keloid formation could inform new therapeutic approaches.
More Related Videos
Related Concept Videos
Clinical Applications of Epidermal Stem Cells
3.4K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
3.4K
Regulation of Hematopoietic Stem Cells
4.4K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
4.4K


